Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
13 Taft Court, Suite 220, Rockville, MD, 20850, US
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production.
By: Charlie Sternberg
Is purpose-built for manufacturing high-quality plasmid DNA and viral vectors.
Is designed to improve efficiency in small-scale experiments.
The Hopewell facility offers an integrated approach to manufacturing with in-house analytical testing, method development, and project management.
By: Rachel Klemovitch
Will develop the plasmid DNA for AAVantgarde’s Stargardt’s disease program (AAVB-039), using its AAV-intein platform.
This plasmid DNA and viral vector manufacturing facility will serve as the hub for North American operations.
Captain T Cell to leverage Charles River’s CGT CDMO expertise to support a T-cell immunotherapy clinical trial.
Facility to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics.
By: Kristin Brooks
Axovia will leverage Charles River’s plasmid platform and expertise in plasmid DNA production to accelerate time to clinic.
Charles River to support the development of novel HOX-based therapies through plasmid DNA manufacturing.
Will manufacture genetic medicines based on Entos Fusogenix PLV platform, including recombinant protein, mRNA, and plasmid DNA.
Will leverage Charles River’s plasmid platform, eXpDNA, and expertise in plasmid DNA production.
4,000-sq.-ft. lab to support drug developers from plasmid DNA to mRNA manufacturing and release.
By: Anthony Vecchione
Charles River to manufacture HQ plasmid DNA for Fondazione Telethon’s lentivirus production.
Alliance will enable GenScript ProBio to accelerate its clinical manufacturing of mRNA-based COVID-19 vaccine, RVM-V001.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
